| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/25/2005 | US20050186639 Gene originating in human chondrocyte |
| 08/25/2005 | US20050186638 Detecting modulators of brain membrane protein; obtained membrane protein incubated with ligand and labeled compound, measure level of binding |
| 08/25/2005 | US20050186631 Nematode PPPT-like sequences |
| 08/25/2005 | US20050186628 Dorsalin-1 polypeptide and uses thereof |
| 08/25/2005 | US20050186627 Cloned peripheral nerve, tetrodotoxin-resistant sodium channel alpha-subunit |
| 08/25/2005 | US20050186626 Chicken leukemia inhibitory factor (LIF) and gene thereof |
| 08/25/2005 | US20050186624 Identifying preferential transcription and/or translational products using luminescent detectors |
| 08/25/2005 | US20050186623 Recovering immunoglobulins from hybridoma cell line; bioreactor and heterologous gene expression |
| 08/25/2005 | US20050186622 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 08/25/2005 | US20050186621 Using host cells to propagate preferential viral proteins for use in generating vaccines aganist microorganismal infection |
| 08/25/2005 | US20050186620 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 08/25/2005 | US20050186619 Nucleic acid analysis using terminal-phosphate-labeled nucleotides |
| 08/25/2005 | US20050186618 ADAM gene having a novel base sequence; an ADAM protein encoded by it has the protease activity and is involved in degradation of an extracellular matrix; recombinant vector comprising the DNA; recombinant host cell |
| 08/25/2005 | US20050186617 Transgenic cell comprising vitamin d3 receptor for use as gene expression diagnostic tool which monitor conversion of ligand precursors into ligands |
| 08/25/2005 | US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186615 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
| 08/25/2005 | US20050186612 Dendritic cell receptor |
| 08/25/2005 | US20050186610 Tumor protein fusion for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186602 Using modified microarray to propagate preferential nucleotide sequences; polymerase chain recation |
| 08/25/2005 | US20050186601 Nucleic acid detection |
| 08/25/2005 | US20050186597 Molecular dissection method using trans-splicing to designed spliced leader sequences, genes, and constructs thereof |
| 08/25/2005 | US20050186596 Methods for screening for proteins comprising a signal sequence |
| 08/25/2005 | US20050186595 Nucleic acid labeling method and liquid composition |
| 08/25/2005 | US20050186594 Antisense oligonucleotides for controlling G protein-coupled receptor kinase 6 and use in the treatment and prevention of rheumatoid arthritis, drug addiction, hypertension, reproductive and blood disorders |
| 08/25/2005 | US20050186591 Method of treating neurodegenerative disease |
| 08/25/2005 | US20050186589 Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi |
| 08/25/2005 | US20050186587 Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor |
| 08/25/2005 | US20050186586 Methods and compositions for enhancing the efficacy and specificity of RNAi |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186574 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 08/25/2005 | US20050186572 Polymerase extension at 3' terminus of PNA-DNA chimera |
| 08/25/2005 | US20050186571 Diagnosis and prevention of cancer cell invasion |
| 08/25/2005 | US20050186570 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 08/25/2005 | US20050186564 Production of proteins |
| 08/25/2005 | US20050186563 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA |
| 08/25/2005 | US20050186562 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time |
| 08/25/2005 | US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy |
| 08/25/2005 | US20050186545 Method of constructing spinal injury model monkey and utilization thereof |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186222 Vaccines against West Nile Virus |
| 08/25/2005 | US20050186219 Transgenic plant-based vaccines |
| 08/25/2005 | US20050186217 Compositions produced using enteric pathogens and methods of use |
| 08/25/2005 | US20050186212 Trefoil factor 3 (TFF3) as a target for anti-cancer therapy |
| 08/25/2005 | US20050186211 Use of mda-5 as an antiviral and antiproliferative agent |
| 08/25/2005 | US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 08/25/2005 | US20050186205 Administering unlabelled anti-CD20 antibody that binds to the CD20 antigen present on lymphoma cells; a second treatment of cyclophosphamide, doxorubicin, vincristine or prednisone |
| 08/25/2005 | US20050186203 Isolated antibody bound to human insulin-like growth factor-I receptor, identification of its CDRs (complementarity-determining regions), inhibiting the tyrosine kinase activity of the IGF-IR receptor |
| 08/25/2005 | US20050186187 Altering the expression levels of a protein; modulating the activity of secretory leukocyte protease inhibitor (SLPI), CD53, or Transferrin-1 in a cell and culturing the cells |
| 08/25/2005 | US20050186186 Tumor cell having DcR3/TR6, a new member of the TNFR family, anchored at its surface |
| 08/25/2005 | US20050186181 Selective precipitation of viruses |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050186179 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/25/2005 | US20050186178 Adenoviral nucleic acid backbone, a heterologous coding sequence encoding granulocyte-macrophage colony stimulating factor |
| 08/25/2005 | DE19903920B4 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses |
| 08/25/2005 | DE19833476B4 Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie Genetically modified CD34-negative adherently growing haematopoietic stem cells and their use in gene therapy |
| 08/25/2005 | DE102004007623A1 Use of specific promoters for expressing genes in Tagetes, useful for preparing biosynthetic products, specifically carotenoids, for use as e.g. pharmaceuticals, also the genetically modified plants |
| 08/25/2005 | DE102004007622A1 Preparation of ketocarotenoids, useful in foods and animal feeds, by growing genetically modified organism that has altered activity of ketolase and beta-cyclase |
| 08/25/2005 | DE102004007032A1 Antisense oligonucleotides hybridizing with mRNA or a gene sequence to code structures inhibiting skin or hair pigmentation act in melanine synthesis, expression of melanosome structures and/or melanosome transfer |
| 08/25/2005 | CA2601952A1 Probe for detecting nuclear receptor agonist or antagonist and method for screening agonist or antagonist to nuclear receptor using the same |
| 08/25/2005 | CA2561504A1 Modified cells that co-express blimp1 and a reporter molecule and methods of using the same |
| 08/25/2005 | CA2558662A1 Method of detecting and identifying gram-negative obligative anaerobic bacterium |
| 08/25/2005 | CA2556088A1 Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
| 08/25/2005 | CA2555848A1 Antibody targeting osteoclast-associated protein |
| 08/25/2005 | CA2555835A1 Method of detecting and identifying lactic acid bacterium |
| 08/25/2005 | CA2555609A1 Expression of plasminogen and microplasminogen in duckweed |
| 08/25/2005 | CA2555531A1 Methods and compositions for combination rnai therapeutics |
| 08/25/2005 | CA2555415A1 Transgenic corn seed with enhanced amino acid content |
| 08/25/2005 | CA2555393A1 Hybrid proteins of active-site serine beta-lactamase |
| 08/25/2005 | CA2555365A1 Methods and compositions for treating tumors and metastatic disease |
| 08/25/2005 | CA2555274A1 Chimeric vegf peptides |
| 08/25/2005 | CA2555145A1 Diagnosis and therapeutics for cancer |
| 08/25/2005 | CA2555142A1 Cell proliferation associated with ccx ckr expression |
| 08/25/2005 | CA2555017A1 Method and kit for identifying function of gene product and identifying binding substance |
| 08/25/2005 | CA2554380A1 Mecp2e1 gene |
| 08/25/2005 | CA2554212A1 Rna interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional sina) |
| 08/25/2005 | CA2554089A1 Albumin fusion proteins |
| 08/25/2005 | CA2550401A1 Method and compositions for detecting botulinum neurotoxin |
| 08/25/2005 | CA2536325A1 Transient production of pharmaceutically important proteins in plants |
| 08/24/2005 | EP1566453A2 Qualitative differential splicing |
| 08/24/2005 | EP1566452A2 Gene information display method and apparatus |
| 08/24/2005 | EP1566451A2 Detection reagent for Shiga toxin family gene of entero-hemorrhagic Escherichia coli |
| 08/24/2005 | EP1566450A2 Reagent and method for detecting the gene 17.5 linked to the MHC of breeding birds |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP1566444A2 Yield-related genes |
| 08/24/2005 | EP1566443A1 Improved transformation of brassica species |
| 08/24/2005 | EP1566442A2 Preparation and use of a human antibody gene bank (human antibody libraries) |
| 08/24/2005 | EP1566441A1 Genes coding for hydroxynitrile lyase, recombinant proteins with hydroxynitrile lyase activity and their use |
| 08/24/2005 | EP1566440A2 Human Interleukin-11 Receptor |
| 08/24/2005 | EP1566438A2 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/24/2005 | EP1566437A1 Adsorption of nucleic acids to a solid phase |
| 08/24/2005 | EP1566436A1 A method for isolating a nucleic acid having an intended functional property anda kit therefor |
| 08/24/2005 | EP1566435A1 ROTARY MOTOR MOLECULE V1-ATPase |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1566386A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 08/24/2005 | EP1566202A1 Use of resistin antagonists in the treatment of rheumatoid arthritis |
| 08/24/2005 | EP1566097A1 Method of in planta transformation of kenaf plant with agrobacterium tumefaciens |
| 08/24/2005 | EP1565583A2 Hiv vaccine formulations |
| 08/24/2005 | EP1565581A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |